| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.46 | 0.002 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.41 | 0.02 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.39 | 0.01 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.38 | 0.04 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.3 | 0.02 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.3 | 0.03 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.29 | 0.09 |